2.21 USD
▼+0.04-1.78%
盘后 2.25 -0.66%
2026-08-03
市值
$23.72M
市盈率
—
EPS
-3.71
股息率
—
52 周区间
1.65 – 3.07
成交量
22.16K
Beta
0.25
目标价
9.50
52W 低 1.6552W 高 3.07
价格走势
公司简介
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatm...